There are some “nectin” proteins that help cancer cells evade the immune system. Israel’s Nectin Therapeutics (at the Hebrew University of Jerusalem) places novel monoclonal antibodies into these nectins to stimulate the immune system and help it fight cancers in … Continue reading →

Israel’s CAPS Medical has developed a small disposable catheter that can reach deep inside the body to deliver cold atmospheric plasma (CAP). The plasma is a stream of high-energy ionized gas that kills solid cancer cells and triggers a tumor-destroying … Continue reading →

Israel’s Immunai is developing a technological platform that aims to map the entire immune system for better detection, diagnosis, and treatment of disease. It uses single cell genomics that could in the future unlock the secrets of infections, cancer and … Continue reading →

Israeli scientists are frequently finding new ways of personalizing cancer treatments. Some are based on genetics (see here) or proteins expressed by the body (see here). Now Weizmann Institute researchers are devising a system to predict how patients will respond … Continue reading →

Israel’s NeoTX uses Selective T cell Redirection (STR) technology to enlist a powerful immune response against tumors. Mutated bacteria are fused with monoclonal antibodies which target the tumor’s 5T4 antigen, alerting T-cells to kill the tumor.  NeoTX has just raised … Continue reading →

The Israel Cancer Research Fund (ICRF) has given $72 million for Israeli cancer research. Much of this is used by scientists to develop treatments that alleviate the damage from chemotherapy, radiation and immunotherapy.  Several examples are given in this link. … Continue reading →

Israel’s Kahr Medical plans to begin human trials of its DSP107 treatment on lung cancer patients. It will be tested both standalone and in combination with Roche’s Tecentriq (atezolizumab). DSP107 finds and marks cancer cells, then alerts the immune system … Continue reading →

I reported previously (31st Dec) on Israel’s Savicell and its ImmunoBiopsy blood test for detecting early stage lung cancer. Savicell’s test checks for the metabolic reactions that the immune system produces when it detects and attacks a tumor. Experts say … Continue reading →

Every year (see here) the Israel Cancer Research Fund (ICRF) awards grants to Israeli researchers working to find cures and treatments for cancer. This year its 69 grants of $4.3 million focus on cancer genetics, targeted cancer therapies and immunotherapy. … Continue reading →

Researchers at Tel Aviv University and Sheba Medical Center have linked metastatic melanoma progression to a patient’s lipid (fatty acid) metabolism. Skin cancer is more sensitive to immune T-cells if the lipid metabolism is high. The scientists say the discovery … Continue reading →